B

네오크레마

311390KOSDAQ

56.0 / 100

Reference Date: 2026-10-23

Financial Score28.5 / 40
News Sentiment12.5 / 25
Momentum5.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Slightly down 1.3% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Neocrema is a functional food ingredient company specializing in microbiome-based products, producing functional sugars and peptides that offer health benefits such as gut environment improvement and blood sugar suppression. Through its subsidiary BB&C, the company diversifies its portfolio with materials and healthcare products, while expanding its market by developing alternative sweeteners and researching skin microbiota. The company also holds international certifications like Halal and Kosher for global exports.

Number of Employees

70people

Average Salary

54.9M KRW

Score Calculation Basis

Detailed Financial Score

PER
9.75Industry Average 15.006.5Point

Lower than industry avg (good)

PBR
0.20Industry Average 1.207.0Point

Half of industry avg (excellent)

ROE
3.58Industry Average 8.001.0Point

Well below industry avg

Debt Ratio
10.64Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20256.0 / 10 points
Revenue Growth Rate
3.0 / 3

Avg ▲82.7% (2-year basis)

Operating Profit Growth Rate
3.0 / 3

Avg ▲267.7% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -2.3% (improving, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position1.0Point

Near 52w low (1%, downtrend)

Current 2,310Won52-week high 7,60052-week low 2,205
1-month return3.0Point

1m -1.28% (flat)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

3 totalPositive 0Neutral 3Negative 0
  • Neutral주식등의대량보유상황보고서(일반)2026-10-06
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-10-06
  • Neutral주식소각결정2026-09-28